help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2004-1132
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
146/2/564    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nantermet, P. V.
Right arrow Articles by Ray, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nantermet, P. V.
Right arrow Articles by Ray, W. J.
Endocrinology Vol. 146, No. 2 564-578
Copyright © 2005 by The Endocrine Society

Androgenic Induction of Growth and Differentiation in the Rodent Uterus Involves the Modulation of Estrogen-Regulated Genetic Pathways

Pascale V. Nantermet, Patricia Masarachia, Michael A. Gentile, Brenda Pennypacker, Jian Xu, Daniel Holder, David Gerhold, Dwight Towler, Azriel Schmidt, Donald B. Kimmel, Leonard P. Freedman, Shun-ichi Harada and William J. Ray

Departments of Molecular Endocrinology and Bone Biology (P.V.N., P.M., M.A.G., B.P., A.S., D.B.K., L.P.F., S.-i.H., W.J.R.), Laboratory Science and Investigative Technology (J.X.), and Biometrics Research (D.H.), Merck Research Labs, West Point Pennsylvania 19401; and Department of Medicine (D.T.), Division of Bone and Mineral Diseases, Washington University School of Medicine, Barnes-Jewish Hospital North Campus, St. Louis, Missouri 63110

Address all correspondence and requests for reprints to: William J. Ray, Department of Molecular Endocrinology, Merck & Co. Inc., P.O. Box 4, WP26A1000, West Point Pennsylvania 19401. E-mail: james_ray{at}merck.com.

The androgen receptor (AR) is expressed in the uterus; however, the role of AR in female reproductive physiology is poorly understood. Here we examined the effects of androgens on uterine growth and gene expression in adult ovariectomized rats. Nonaromatizable AR-selective agonists potently stimulate hypertrophy and induce significant myometrial expansion distinct from that induced by 17ß-estradiol (E2). In the endometrium, androgens only modestly increase epithelial cell height and antagonize the trophic effects of E2. To identify underlying mechanisms, global changes in RNA levels 24 h after stimulation with E2 and 5{alpha}-dihydrotestosterone (DHT) were compared. A total of 491 genes were differentially expressed after E2 treatment, including key regulators of tissue remodeling, cell signaling, metabolism, and gene expression. Of the 164 transcripts regulated by DHT, 86% were also affected by E2, including trophic genes like IGF-I and epithelial secretory genes such as uterocalin. In estrogen receptor (ER){alpha} knockout mice, DHT cannot induce uterine growth, suggesting a key role for ER{alpha}. However, DHT appears not to activate ER{alpha} directly because DHT induction of IGF-I is blocked by the AR antagonist bicalutamide, and multiple genes regulated directly by ER{alpha} were not induced by DHT. The similarity between estrogens and androgens instead could reflect general trophic signaling in reproductive tissues because 93 of the 503 genes regulated in the uterus are similarly affected during prostate growth. Thus androgens regulate the trophic environment and architecture of the rodent uterus via a gene expression program that is overlapping but distinct from the estrogen response.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Shao, K. Ljungstrom, B. Weijdegard, E. Egecioglu, J. Fernandez-Rodriguez, F.-P. Zhang, A. Thurin-Kjellberg, C. Bergh, and H. Billig
Estrogen-induced upregulation of AR expression and enhancement of AR nuclear translocation in mouse fallopian tubes in vivo
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E604 - E614.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. A. Arias-Loza, K. Hu, A. Schafer, J. Bauersachs, T. Quaschning, J. Galle, V. Jazbutyte, L. Neyses, G. Ertl, K.-H. Fritzemeier, et al.
Medroxyprogesterone Acetate But Not Drospirenone Ablates the Protective Function of 17{beta}-Estradiol in Aldosterone Salt-Treated Rats
Hypertension, November 1, 2006; 48(5): 994 - 1001.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. C. Hewitt, J. Collins, S. Grissom, K. Hamilton, and K. S. Korach
Estren Behaves as a Weak Estrogen Rather than a Nongenomic Selective Activator in the Mouse Uterus
Endocrinology, May 1, 2006; 147(5): 2203 - 2214.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society